Literature DB >> 6693604

Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.

N J Lowe, R E Ashton, H Koudsi, M Verschoore, H Schaefer.   

Abstract

Anthralin is an effective topical drug for psoriasis therapy. Recent studies have suggested that anthralin may be effective in high concentrations for short periods of skin contact. The purpose of these studies was to compare psoriasis improvement rates in patients treated with 0.3% anthralin ointment for 10 minutes' skin contact daily with patients treated with a topical steroid, difluorosone diacetate. A further study conducted was a bilateral paired comparison between conventional strength (0.1%-0.5%) anthralin ointment overnight with high concentration anthralin (0.5%-3%) for short contact periods of 10 minutes daily. The results showed good responses in all treatment groups. Short-contact anthralin is confirmed as a practical means of outpatient therapy for psoriasis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693604     DOI: 10.1016/s0190-9622(84)80046-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Short-contact anthralin therapy for psoriasis.

Authors:  H E Fleischmann
Journal:  West J Med       Date:  1987-10

2.  Phototherapy and dithranol treatment of psoriasis.

Authors:  N J Lowe
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.